As of April 3, 2026, Heartbeam Inc. (BEAT), a developer of remote cardiac diagnostic and monitoring solutions, trades at a current price of $1.18, marking a 3.28% decline in intraday trading. This analysis focuses on key technical levels, recent market context, and potential near-term trading scenarios for the stock, as no recent earnings data has been released to drive fundamental sentiment as of this writing. Over recent weeks, BEAT has traded in a relatively tight range, with technical suppor
BEAT Stock Analysis: Heartbeam Inc. drops 3.28% to $1.18 testing key short-term support
BEAT - Stock Analysis
3681 Comments
1714 Likes
1
Danicah
Power User
2 hours ago
Free US stock supply chain analysis and economic moat sustainability research to understand long-term competitive position. We evaluate business models and structural advantages that protect companies from competitors.
👍 247
Reply
2
Malacki
Regular Reader
5 hours ago
This came at the wrong time for me.
👍 50
Reply
3
Serrina
Engaged Reader
1 day ago
So late to read this…
👍 72
Reply
4
Thersia
Influential Reader
1 day ago
Free US stock correlation to major indices and sector benchmarks for performance attribution analysis and return source identification. We help you understand how your portfolio moves relative to broader market benchmarks and identify return drivers. We provide correlation analysis, attribution breakdown, and benchmark comparison for comprehensive coverage. Understand performance drivers with our comprehensive correlation and attribution analysis tools for portfolio optimization.
👍 276
Reply
5
Sachary
Elite Member
2 days ago
Free US stock sector relative performance and leadership analysis to identify market themes and trends. Our sector analysis helps you understand which parts of the market are leading and lagging the broader index.
👍 153
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.